224 related articles for article (PubMed ID: 12466268)
1. Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Schneider P; Olson D; Tardivel A; Browning B; Lugovskoy A; Gong D; Dobles M; Hertig S; Hofmann K; Van Vlijmen H; Hsu YM; Burkly LC; Tschopp J; Zheng TS
J Biol Chem; 2003 Feb; 278(7):5444-54. PubMed ID: 12466268
[TBL] [Abstract][Full Text] [Related]
2. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.
Walczak H; Degli-Esposti MA; Johnson RS; Smolak PJ; Waugh JY; Boiani N; Timour MS; Gerhart MJ; Schooley KA; Smith CA; Goodwin RG; Rauch CT
EMBO J; 1997 Sep; 16(17):5386-97. PubMed ID: 9311998
[TBL] [Abstract][Full Text] [Related]
3. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
Kamohara H; Matsuyama W; Shimozato O; Abe K; Galligan C; Hashimoto S; Matsushima K; Yoshimura T
Immunology; 2004 Feb; 111(2):186-94. PubMed ID: 15027904
[TBL] [Abstract][Full Text] [Related]
4. Characterization of two receptors for TRAIL.
Schneider P; Bodmer JL; Thome M; Hofmann K; Holler N; Tschopp J
FEBS Lett; 1997 Oct; 416(3):329-34. PubMed ID: 9373179
[TBL] [Abstract][Full Text] [Related]
5. Identification of tumor necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL) and its receptors in adult rat ventral prostate.
Vindrieux D; Devonec M; Benahmed M; Grataroli R
Mol Cell Endocrinol; 2002 Dec; 198(1-2):115-21. PubMed ID: 12573821
[TBL] [Abstract][Full Text] [Related]
6. TRAIL and KILLER are expressed and induce apoptosis in the murine preimplantation embryo.
Riley JK; Heeley JM; Wyman AH; Schlichting EL; Moley KH
Biol Reprod; 2004 Sep; 71(3):871-7. PubMed ID: 15128592
[TBL] [Abstract][Full Text] [Related]
7. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand.
Chou AH; Tsai HF; Lin LL; Hsieh SL; Hsu PI; Hsu PN
J Immunol; 2001 Aug; 167(3):1347-52. PubMed ID: 11466352
[TBL] [Abstract][Full Text] [Related]
8. Production of recombinant TRAIL and TRAIL receptor: Fc chimeric proteins.
Schneider P
Methods Enzymol; 2000; 322():325-45. PubMed ID: 10914028
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis-mediating receptor-ligand systems in human retinal pigment epithelial cells.
Hueber A; Aduckathil S; Kociok N; Welsandt G; Dinslage S; Kirchhof B; Esser PJ
Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):551-6. PubMed ID: 12136286
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor.
Wu GS; Burns TF; Zhan Y; Alnemri ES; El-Deiry WS
Cancer Res; 1999 Jun; 59(12):2770-5. PubMed ID: 10383128
[TBL] [Abstract][Full Text] [Related]
11. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
Mirandola P; Ponti C; Gobbi G; Sponzilli I; Vaccarezza M; Cocco L; Zauli G; Secchiero P; Manzoli FA; Vitale M
Blood; 2004 Oct; 104(8):2418-24. PubMed ID: 15205263
[TBL] [Abstract][Full Text] [Related]
12. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family.
Degli-Esposti MA; Smolak PJ; Walczak H; Waugh J; Huang CP; DuBose RF; Goodwin RG; Smith CA
J Exp Med; 1997 Oct; 186(7):1165-70. PubMed ID: 9314565
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines.
Shetty S; Gladden JB; Henson ES; Hu X; Villanueva J; Haney N; Gibson SB
Apoptosis; 2002 Oct; 7(5):413-20. PubMed ID: 12207174
[TBL] [Abstract][Full Text] [Related]
15. Tissue distribution of the death ligand TRAIL and its receptors.
Spierings DC; de Vries EG; Vellenga E; van den Heuvel FA; Koornstra JJ; Wesseling J; Hollema H; de Jong S
J Histochem Cytochem; 2004 Jun; 52(6):821-31. PubMed ID: 15150291
[TBL] [Abstract][Full Text] [Related]
16. The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival.
Pritzker LB; Scatena M; Giachelli CM
Mol Biol Cell; 2004 Jun; 15(6):2834-41. PubMed ID: 15064358
[TBL] [Abstract][Full Text] [Related]
17. An antagonist decoy receptor and a death domain-containing receptor for TRAIL.
Pan G; Ni J; Wei YF; Yu G; Gentz R; Dixit VM
Science; 1997 Aug; 277(5327):815-8. PubMed ID: 9242610
[TBL] [Abstract][Full Text] [Related]
18. TRAIL and NFkappaB signaling--a complex relationship.
Wajant H
Vitam Horm; 2004; 67():101-32. PubMed ID: 15110174
[TBL] [Abstract][Full Text] [Related]
19. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling.
Pan G; Ni J; Yu G; Wei YF; Dixit VM
FEBS Lett; 1998 Mar; 424(1-2):41-5. PubMed ID: 9537512
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.
Perlman H; Nguyen N; Liu H; Eslick J; Esser S; Walsh K; Moore TL; Pope RM
Arthritis Rheum; 2003 Nov; 48(11):3096-101. PubMed ID: 14613271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]